Novartis AG Net Worth 2006-2019 | NVS

Interactive chart of historical net worth (market cap) for Novartis AG (NVS) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Novartis AG net worth as of August 21, 2019 is $204.38B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $204.376B $51.900B
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $344.675B 15.01
Roche Holding AG (RHHBY) Switzerland $237.187B 0.00
Merck (MRK) United States $219.296B 18.03
Pfizer (PFE) United States $191.430B 11.27
Novo Nordisk (NVO) Denmark $125.629B 21.46
AstraZeneca (AZN) United Kingdom $113.018B 22.65
Eli Lilly (LLY) United States $107.173B 20.00
Sanofi (SNY) France $106.344B 13.11
GlaxoSmithKline (GSK) United Kingdom $99.869B 12.62
AbbVie (ABBV) United States $98.186B 7.87
Bristol-Myers Squibb (BMY) United States $77.912B 11.05
Bayer (BAYRY) Germany $68.268B 9.95
H Lundbeck (HLUYY) Denmark $7.654B 11.05